Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBALIZUMAB-UIYK vs IBANDRONATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IBALIZUMAB-UIYK vs IBANDRONATE: Safety Overview

Metric IBALIZUMAB-UIYK IBANDRONATE
Total FAERS Reports 418 10,178
Deaths Reported 31 236
Death Rate 7.4% 2.3%
Hospitalizations 94 1,420
Average Patient Age 56.0 yrs 69.0 yrs
% Female Patients 22.8% 95.4%
FDA Approval Date N/A Apr 30, 2012
Manufacturer N/A Eugia US LLC
Route N/A INTRAVENOUS
Marketing Status Prescription Discontinued